结直肠癌患者肿瘤浸润 T 细胞中免疫检查点和 T 细胞耗竭标志物的表观遗传调控。

Epigenetic regulation of immune checkpoints and T cell exhaustion markers in tumor-infiltrating T cells of colorectal cancer patients.

机构信息

Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O.Box: 34110, Doha, Qatar.

Department of Surgery, Hamad Medical Corporation, Doha, Qatar.

出版信息

Epigenomics. 2020 Nov;12(21):1871-1882. doi: 10.2217/epi-2020-0267. Epub 2020 Nov 10.

Abstract

To elucidate the epigenetic alterations behind the upregulation of immune checkpoints and T cell exhaustion markers in colorectal cancer (CRC) patients. mRNA expressions of different immune checkpoint/exhaustion markers were analyzed by quantitative real-time reverse transcriptase PCR and epigenetic investigations were performed using bisulfite sequencing and chromatin immunoprecipitation quantitative PCR. mRNA expressions of PD-1, TIM-3, CTLA-4, PD-L1 and TOX2 were significantly upregulated in CD4 and CD8 tumor-infiltrating lymphocytes and bulk CRC tumor tissues. Histone 3 lysine 9 trimethylation was downregulated and histone 3 lysine 4 trimethylation was upregulated in PD-L1 and TOX2 promoters in tumor tissues, suggesting that and upregulation in CRC tumors could be mediated by activating histone 3 lysine 4 trimethylation. Epigenetic modifications in promoters of immune checkpoint and T cell exhaustion genes could induce their upregulation, and potentially implicate the use of epigenetic modifiers to enhance antitumor immunity in CRC patients.

摘要

为了阐明结直肠癌(CRC)患者中免疫检查点和 T 细胞耗竭标志物上调的表观遗传改变。通过定量实时逆转录 PCR 分析了不同免疫检查点/耗竭标志物的 mRNA 表达,并通过亚硫酸氢盐测序和染色质免疫沉淀定量 PCR 进行了表观遗传研究。PD-1、TIM-3、CTLA-4、PD-L1 和 TOX2 的 mRNA 在 CD4 和 CD8 肿瘤浸润淋巴细胞和 CRC 肿瘤组织中均显著上调。在肿瘤组织中,PD-L1 和 TOX2 启动子中的组蛋白 3 赖氨酸 9 三甲基化下调,组蛋白 3 赖氨酸 4 三甲基化上调,表明 CRC 肿瘤中 PD-L1 和 TOX2 的上调可能是通过激活组蛋白 3 赖氨酸 4 三甲基化介导的。免疫检查点和 T 细胞耗竭基因启动子中的表观遗传修饰可诱导其上调,并可能暗示使用表观遗传修饰剂来增强 CRC 患者的抗肿瘤免疫。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索